23 results
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
7 May 24
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:15am
on alleviating the substantial unmet medical need in neuropsychiatric and neurodegenerative diseases with multiple targets that are supported by strong
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
and competitive. Compensation of our executives is structured around the achievement of individual performance and near-term corporate targets as well as long
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
in large part to an insufficient degree of focus on novel, potentially more therapeutically relevant targets implicated in CNS diseases and clinical … a broad range of novel targets to potentially bring forward the next generation of therapies. We will look to efficiently establish proof-of-concept
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
Neuropsychiatry Portfolio Pursuing Large Markets with Clinically Validated Targets Differentiated programs with broad potential Navacaprant NMRA-266 NMRA
10-Q
nsak8ka1i mvh7e
1 Nov 23
Quarterly report
4:05pm
S-8
EX-99.1
azb49i 7t1cm
19 Sep 23
Registration of securities for employees
9:57pm
S-8
EX-99.3
5pgh0mjq6xa
19 Sep 23
Registration of securities for employees
9:57pm
424B4
df4i3
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
agn7jh tx7cm
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.6
f0eppz3uplrl7or84x
25 Aug 23
IPO registration
5:03pm
S-1
t0mtzz6ylkm
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.7
f8w8z1865hydibq1b
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.2
prio0tej
25 Aug 23
IPO registration
5:03pm
DRS/A
5sev 5cba
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
afkhdxu7uyw4ifx6t 04
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
r0j33c 66l84mo
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
ngtd0 f7d8v
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
fqnqj1
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
4n1lbv4
10 Jun 22
Draft registration statement (amended)
12:00am